Imperial Valley News Center

Details

Written by State Department

Washington, DC - Today the U.S. Department of State and the U.S. Agency for International Development are releasing the U.S. government’s Global Water Strategy.

Details

Written by IVN

Washington, DC - The U.S. Food and Drug Administration today authorized Memorial Sloan Kettering Cancer Center’s (MSK) IMPACT (Integrated Mutation Profiling of Actionable Cancer Targets) tumor profiling test (assay), an in vitro diagnostic test that can identify a higher number of genetic mutations (biomarkers) that may be found in various cancers than any test previously reviewed by the agency. The IMPACT test uses next-generation sequencing (NGS) to rapidly identify the presence of mutations in 468 unique genes, as well as other molecular changes in the genomic makeup of a person’s tumor. Cancer profile tests are gaining wider acceptance. By identifying what genetic mutations are present in a particular tumor, the test results can provide patients and health care professionals with useful insight that may help inform how best to treat the cancer.

Details

Written by Danielle Nierenberg, Food Tank

Washington, DC - The international community will gather in the second week of November to evaluate the progress that the 196 signatory countries to the Paris Climate Agreement have made since 2015. This will be the first global meeting of the signatories since President Donald Trump threatened to withdraw the United States (U.S.), the world’s second most significant emitter, from the agreement.

Details

Written by State Department

Washington, DC - The United States congratulates the city of Buenos Aires and the Government of Argentina for winning the right to host Expo 2023 as a result of today’s vote at the 162nd General Assembly meeting of the Bureau of International Expositions in Paris, France.